- ►annals.org C Feray, M Gigou, D Samuel, B Ducot, P … - Annals of internal …, 1998 - Am Coll Physicians Background: Recurrence of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection after liver
transplantation is a clinical problem. Polyclonal immunoglobulins against hepatitis B surface
antigen (HBIGs) prevent the recurrence of HBV infection, but no effective prophylaxis is ... Cited by 91 - Related articles - BL Direct - All 4 versions
N Singh, T Gayowski, CF Wannstedt, AO Shakil, MM … - Transplantation, 1998 - journals.lww.com Skip Navigation Links Home > January 15, 1998 - Volume 65 - Issue 1 >
INTERFERON-[alpha] FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATI... ... Singh,
Nina; Gayowski, Timothy; Wannstedt, Cheryl F.; Shakil, A. Obaid; Wagener, Marilyn M.; ... Cited by 132 - Related articles - BL Direct - All 4 versions
PA Sheiner, P Boros, FM Klion, SN Thung, LK … - Hepatology, 1998 - interscience.wiley.com Clinical recurrence of hepatitis C after liver transplantation can lead to cirrhosis, liver failure,
and death. In patients undergoing liver transplantation for hepatitis C, we assessed the efficacy
of interferon alfa-2b (IFN) in preventing recurrent hepatitis. We randomized 86 patients to ... Cited by 177 - Related articles - BL Direct - All 3 versions
K Krawczynski, MJ Alter, DL Tankersley, M Beach, … - The Journal of infectious …, 1996 - jstor.org Effect of Immune Globulin on the Prevention of ... Krzysztof Krawczynski, Miriam J. Alter, Donald
L. Tankersley, Michael Beach, Betty H. Robertson, Stephen Lambert, George Kuo, John E.
Spelbring, Emory Meeks, Saswati Sinha, and Dorrie A. Carson Cited by 131 - Related articles - BL Direct - All 3 versions
P pratiques en France - Hépato-Gastro, 1995 - john-libbey-eurotext.fr L'infection par le virus de l'hépatite C (VHC) est détectée chez 25 % des candidats à une transplantation
hépatique. Les résultats à court terme, dans cette indication, sont bons avec 85 % de survie à
5 ans [1]. Néanmoins, la persistance constante de l'infection après la transplantation [2], ... Related articles - All 2 versions
C Féray, D Samuel, M Gigou, V Paradis, MF David, … - Hepatology, 1995 - interscience.wiley.com The aim of this open trial was to assess the efficacy and the safety of interferon (IFN) alfa therapy
in liver transplant recipients with chronic active hepatitis caused by hepatitis C virus. In July
1991, among 447 liver recipients regularly observed at our institution, 46 had developed ... Cited by 218 - Related articles - BL Direct - All 3 versions
- ►pnas.org MW Yu, B Bartosch, P Zhang, Z Guo, PM … - Proceedings of the …, 2004 - National Acad Sciences The role of humoral immunity in hepatitis C virus (HCV) infections is uncertain. Nevertheless,
there is increasing evidence for neutralizing antibodies to HCV in the serum or plasma of chronically
infected individuals. Immune globulins prepared by ethanol fractionation of plasma had ... Cited by 81 - Related articles - BL Direct - All 11 versions
K Ishii, D Rosa, Y Watanabe, T Katayama, H … - Hepatology, 1998 - interscience.wiley.com Most cases of hepatitis C virus (HCV) infection result in chronic disease; however, a very small
fraction of patients naturally clear the virus and resolve chronic hepatitis. In an attempt to correlate
immune response with chronic disease resolution, we compared the antibody response ... Cited by 118 - Related articles - BL Direct - All 3 versions
HR Rosen, PM O'Reilly, CR Shackleton, S McDiarmid … - Transplantation, 1996 - journals.lww.com Liver disease due to hepatitis C (HCV) is an increasingly frequent indication for orthotopic liver
transplantation (OLT). The aim of the current study was to analyze the causes of graft loss following
OLT for chronic hepatitis C and the longterm outcome following retransplantation in a ... Cited by 72 - Related articles - BL Direct - All 3 versions
